Back
Endava PLC Vs. MoonLake Immunotherapeutics Industry Stock Comparison
Sell
29
DAVA
Endava PLC
Last Price:
$13.78
Seasonality Move:
9.69%
Sell
46
MLTX
MoonLake Immunotherapeutics
Last Price:
$44.88
Seasonality Move:
43.23%
Sell
29
Endava PLC (DAVA)
is a Sell
Is Endava PLC a Buy, Sell or Hold?
-
The current Endava PLC [DAVA] share price is $13.81. The Score for DAVA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
DAVA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics a Buy, Sell or Hold?
-
The current MoonLake Immunotherapeutics [MLTX] share price is $44.87. The Score for MLTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
MLTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DAVA Stock Price Chart
What is Endava PLC's stock price today?
-
The Endava PLC share price today is $13.81Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DAVA is experiencing slight buying pressure.
MLTX Stock Price Chart
What is MoonLake Immunotherapeutics's stock price today?
-
The MoonLake Immunotherapeutics share price today is $44.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
DAVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.51 | Sell |
Relative Strength Index (14 RSI): | 33.57 | Sell |
Chaikin Money Flow: | 526991 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
MLTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.02 | Buy |
Relative Strength Index (14 RSI): | 56.93 | Buy |
Chaikin Money Flow: | 376483 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.9 - 46.48) | Buy |
Bollinger Bands (100): | (37.45 - 44.31) | Buy |
DAVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.16 | Sell |
20-day SMA: | 15.43 | Sell |
50-day SMA: | 16.82 | Sell |
200-day SMA: | 24.8 | Sell |
8-day EMA: | 14.85 | Sell |
20-day EMA: | 15.5 | Sell |
50-day EMA: | 15.16 | Sell |
200-day EMA: | 8.2 | Buy |
MLTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.77 | Buy |
20-day SMA: | 43.65 | Buy |
50-day SMA: | 40.74 | Buy |
200-day SMA: | 45.57 | Sell |
8-day EMA: | 44.08 | Buy |
20-day EMA: | 43.43 | Buy |
50-day EMA: | 41.94 | Buy |
200-day EMA: | 43.69 | Buy |
Endava PLC Earnings Growth & DAVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.03 per share, an increase this year of $0.01 per share, and an increase next year of $0.14 per share.
MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.20 per share, and a decrease next year of $0.62 per share.
Endava PLC Technical Analysis
Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
MoonLake Immunotherapeutics Technical Analysis
Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |